AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. He received slow-release Madopar 250 mg and Madopar 375 mg per day for his PD. He suffered an L3 compression fracture in an accident and was hospitalized for surgery because of severe back pain. He was referred to a psychiatrist because of severe depression. Duloxetine (30 mg twice per day, without titration) was prescribed for both antidepressant and analgesic effects. This regimen was continued for 7 months with no deterioration in cognitive function, and no worsening of PD was observed in his monthly follow-up. Duloxetine, which is a serotonin and noradrenaline reuptake inhibitor, may have the same antidepressant effect as tricyclic antide...
International audienceDepression is one of the most common psychiatric disturbances in Parkinson's d...
Parkinsonism is a neurological syndrome characterized by resting tremor, stiffness in cogwheels, pos...
Introduction: Although antidepressants are widely used in Parkinson's disease (PD), few well-designe...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Objective: Depression is a comorbidity affecting quality of life (QoL) in patients with Parkinson's ...
PURPOSE: To assess and compare the levels of functioning in patients with major depressive disorder ...
© 2020 Shahrul Azmin Bin Md. RaniPain in Parkinsons disease is common and poorly managed. The body o...
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most sev...
The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper descri...
BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms o...
SUMMARYDepression has a negative impact on activities of daily living, cognitive performance, and qu...
Background: Major depressive disorder (MDD) is a chronic and highly disabling condition. Existing ph...
Duloxetine is a serotonin-noradrenaline reuptake inhibitor with established efficacy for the short-t...
The aim of the present paper was to compare the efficacy and safety of duloxetine with paroxetine in...
AbstractTreatment-resistant depression is a difficult problem in clinical practice. Evidence for the...
International audienceDepression is one of the most common psychiatric disturbances in Parkinson's d...
Parkinsonism is a neurological syndrome characterized by resting tremor, stiffness in cogwheels, pos...
Introduction: Although antidepressants are widely used in Parkinson's disease (PD), few well-designe...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Objective: Depression is a comorbidity affecting quality of life (QoL) in patients with Parkinson's ...
PURPOSE: To assess and compare the levels of functioning in patients with major depressive disorder ...
© 2020 Shahrul Azmin Bin Md. RaniPain in Parkinsons disease is common and poorly managed. The body o...
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most sev...
The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper descri...
BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms o...
SUMMARYDepression has a negative impact on activities of daily living, cognitive performance, and qu...
Background: Major depressive disorder (MDD) is a chronic and highly disabling condition. Existing ph...
Duloxetine is a serotonin-noradrenaline reuptake inhibitor with established efficacy for the short-t...
The aim of the present paper was to compare the efficacy and safety of duloxetine with paroxetine in...
AbstractTreatment-resistant depression is a difficult problem in clinical practice. Evidence for the...
International audienceDepression is one of the most common psychiatric disturbances in Parkinson's d...
Parkinsonism is a neurological syndrome characterized by resting tremor, stiffness in cogwheels, pos...
Introduction: Although antidepressants are widely used in Parkinson's disease (PD), few well-designe...